| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_440b3059c9bcd1d85fd383f9b2ae1b40 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2007-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7be9ff4c7d7b8ce2ac2b5666cbd5f94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc2588f1c9873945eef387761e0b540e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aabd7291024cc1ca8fd8124e40d055a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f941d30bd5791f84eaa8fac004c2431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0109121bcbeb3b6b9863ffb3d1c2b6cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b05690a4c94c592d33f74f679f353d04 |
| publicationDate |
2009-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2009046413-A |
| titleOfInvention |
N-acetylglucosamine sugar chain recognition protein |
| abstract |
Disclosed is an N-acetylglucosamine sugar chain recognition protein present in smooth muscle cells, cardiomyocytes and skeletal myoblasts at the site of vascular injury, and a drug that can be easily produced by specifically transporting a drug to this site via this protein. And a drug transporter. An N-acetylglucosamine sugar chain-recognizing protein is extracted by dissolving a protein group from extracted cardiomyocytes or vascular smooth muscle cells and binding to a substance containing an N-acetylglucosamine sugar chain group from the extracted protein group. Which can be separated and purified. The drug contains N-acetylglucosamines that bind to an N-acetylglucosamine sugar chain recognition protein. The drug transporter is one in which N-acetylglucosamines that bind to the N-acetylglucosamine sugar chain recognition protein are exposed from the surface of the colloidal particles. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11160877-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10918726-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170012369-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10772973-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017204337-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10471158-B2 |
| priorityDate |
2007-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |